Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haplotype tagging in pharmacogenetics.

David B Goldstein1

  • 1Department of Biology, Darwin Building, University College London, Gower Street, London WC1E 6BT, UK.

Novartis Foundation Symposium
|July 8, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision Diagnosis in APOL1 Kidney Disease With the p.N264K M1 Protective Variant.

JAMA network open·2026
Same author

The impact of TRPV4 pathogenic mutations on barrier integrity.

Human molecular genetics·2025
Same author

RNA methyltransferase SPOUT1/CENP-32 links mitotic spindle organization with the neurodevelopmental disorder SpADMiSS.

Nature communications·2025
Same author

Natural History and Clinicopathological Associations of TRPC6-Associated Podocytopathy.

Journal of the American Society of Nephrology : JASN·2024
Same author

Do germline genetic variants influence surgical outcomes in drug-resistant epilepsy?

Epilepsy research·2024
Same author

Rare variant analyses validate known ALS genes in a multi-ethnic population and identifies ANTXR2 as a candidate in PLS.

BMC genomics·2024

This study introduces haplotype mapping to analyze genetic variations in drug-metabolizing genes. These findings help identify genetic markers for personalized medicine and new drug targets.

Area of Science:

  • Pharmacogenomics
  • Human Population Genetics
  • Molecular Biology

Background:

  • Understanding human genetic variation is crucial for disease predisposition and drug response.
  • Genetic variations in drug-metabolizing and transporting genes significantly impact treatment efficacy.
  • Haplotype mapping offers a framework to analyze complex genetic patterns.

Purpose of the Study:

  • To develop and present a framework for linkage disequilibrium (haplotype)-based gene mapping.
  • To identify haplotype tagging single nucleotide polymorphisms (SNPs) for major drug-metabolizing enzymes.
  • To explore applications of haplotype mapping in clinical diagnostics and therapeutic target discovery.

Main Methods:

  • Analysis of genetic variation in 56 key drug-metabolizing and transporting genes.

Related Experiment Videos

  • Genotyping of 754 single nucleotide polymorphisms (SNPs) in European and Japanese population samples.
  • Haplotype reconstruction and tagging SNP identification.

    • Main Results:

    • A set of cost-effective haplotype tagging SNPs was identified, efficiently representing genetic variation in major drug-metabolizing enzymes.
    • The study provides insights into outstanding questions in haplotype mapping.
    • Established a foundation for translating genotype-phenotype correlations.

    Conclusions:

    • Haplotype mapping is a powerful tool for understanding genetic variation in drug response.
    • Identified SNPs can facilitate the development of clinically useful diagnostics.
    • This approach can accelerate the discovery of novel therapeutic targets.